Cite
MLA Citation
A Abdelmoula et al.. “P494 Impact of early optimization of ustekinumab on mid-term targets in severe Crohn's disease: THE MUST study.” Journal of Crohn's and colitis, vol. 17, n.d., p. i625. http://access.bl.uk/ark:/81055/vdc_100179844218.0x000024